JO
FBRX icon

John Overdeck’s Forte Biosciences FBRX Stock Holding History

John Overdeck’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Sell
13,411
-2,098
-14% -$49.7K ﹤0.01% 4563
2026
Q1 		$402K Sell
15,509
-16,299
-51% -$470K ﹤0.01% 3880
2025
Q4 		$867K Buy
+31,808
New +$558K ﹤0.01% 3030
2024
Q3 		– Sell
-1,632
Closed -$21.9K – 3178
2024
Q2 		$21.9K Sell
1,632
-3
-0.2% -$48 ﹤0.01% 2934
2024
Q1 		$28.4K Sell
1,635
-4
-0.2% -$70 ﹤0.01% 2916
2023
Q4 		$33.7K Sell
1,639
-16
-1% -$224 ﹤0.01% 3028
2023
Q3 		$27.4K Sell
1,655
-660
-29% -$14.6K ﹤0.01% 2855
2023
Q2 		$60.2K Sell
2,315
-20
-0.9% -$520 ﹤0.01% 2806
2023
Q1 		$58.9K Sell
2,335
-184
-7% -$4.63K ﹤0.01% 2729
2022
Q4 		$63K Sell
2,519
-1,365
-35% -$35K ﹤0.01% 2567
2022
Q3 		$104K Sell
3,884
-1,008
-21% -$32K ﹤0.01% 2224
2022
Q2 		$159K Sell
4,892
-4,564
-48% -$145K ﹤0.01% 2207
2022
Q1 		$345K Sell
9,456
-2,344
-20% -$88.7K ﹤0.01% 2165
2021
Q4 		$631K Buy
+11,800
New +$794K ﹤0.01% 3020
2020
Q4 		– Sell
-500
Closed -$606K – 3446
2020
Q3 		$606K Buy
+500
New +$331K ﹤0.01% 2093
2020
Q2 		– Sell
-38
Closed -$17K – 3109
2020
Q1 		$17K Sell
38
-239
-86% -$93.4K ﹤0.01% 2976
2019
Q4 		$55K Buy
277
+112
+68% +$25.4K ﹤0.01% 3566
2019
Q3 		$41K Buy
+165
New +$250K ﹤0.01% 3358

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

John Overdeck's FBRX Position: Q2 2026 in Review

John Overdeck reduced its Forte Biosciences (FBRX) stake by 14% in Q2 2026, selling an estimated $49.7K and leaving 13,411 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #4563.

John Overdeck first reported a position in FBRX in Q3 2019 and has held it in 18 quarters since. The position peaked at $867K in Q4 2025. 85 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • John Overdeck held 13,411 shares of Forte Biosciences worth $285K as of Q2 2026.
  • John Overdeck sold 2,098 Forte Biosciences shares in Q2 2026, an estimated $49.7K.
  • Forte Biosciences made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4563 holding.
  • John Overdeck first reported a position in Forte Biosciences in Q3 2019 and has held it in 18 quarters since.
  • John Overdeck's Forte Biosciences position peaked at $867K in Q4 2025.
  • 85 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.